£108.00

Springer Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Price data last checked 12 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical
Generating forecast…
£108.00 £107.98 £107.98 £107.99 £107.99 £108.00 £108.00 01 May 2026 19 May 2026 06 June 2026 24 June 2026 13 July 2026

Price Distribution

Price distribution over 74 days • 1 price levels

Days at Price
74 days 0 19 37 56 74 £108 Days at Price

Price Analysis

Most common price: £108 (74 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 74 days

Description

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients. From the Back Cover "There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis." Challenging Charcot’s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and possible treatments of MS. Assuming oligodendrocyte injury as a prerequisite to MS, the authors explore viruses, toxins and genetic defects as possible culprits. They present novel methods to interrupt and reverse demyelination. This book examines the correlation between axonal loss and clinical deficits, including the implied role of the CD8+ T cell and perforin. It assesses proteases, specifically, kallikrein 6, which are strongly associated with active demyelination. By directing natural autoantibodies against oligodendrocytes that demonstrate remyelination in animal models, the authors envision clinical trials for remyelination enhancement. As internationally recognized specialists in a wide range of MS disciplines, the authors explore genetic tools for identifying patients who are most likely to experience spontaneous remyelination. Epidemiology studies offer additional avenues of treatment. Examples include uric acid, statin drugs, estrogen and progesterone. MS affects nearly 400,000 people in the United States, many of whom are between18 and 40 years of age. With their novel, multifaceted approach to basic science―and their applications in understanding cause and treatment―the authors offer help to clinicians and hope to patients.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
25 September 2014
Listed Since
25 September 2014

Barcode

No barcode data available

Similar Products You Might Like

Myelin Repair and Neuroprotection in Multiple Sclerosis
98% match

Myelin Repair and Neuroprotection in Multiple Sclerosis

Springer

£88.19 07 Jul 2026
International Review of Neurobiology,79: Volume 79
97% match

International Review of Neurobiology,79: Volume 79

Academic Press

£120.36 11 Jul 2026
Multiple Sclerosis: A Mechanistic View
97% match

Multiple Sclerosis: A Mechanistic View

Academic Press

£95.00 08 Jul 2026
The Biology of Multiple Sclerosis (Cambridge Medicine (Hardcover))
97% match

The Biology of Multiple Sclerosis (Cambridge Medicine (Hardcover))

Cambridge University Press

£40.50 16 Jul 2026
Multiple Sclerosis: A Practical Manual for Hospital and Outpatient Care (Cambridge Manuals in Neurology)
97% match

Multiple Sclerosis: A Practical Manual for Hospital and Outpatient Care (Cambridge Manuals in Neurology)

Cambridge University Press

£40.94 08 Jul 2026
Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments: 26 (Current Topics in Behavioral Neurosciences)
97% match

Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments: 26 (Current Topics in Behavioral Neurosciences)

Springer

£89.94 04 Jul 2026
Progressive Multiple Sclerosis
97% match

Progressive Multiple Sclerosis

Springer

£144.00 15 Jul 2026
Multiple Sclerosis: Clinician's Guide To Diagnosis And Treatment (Oxford American Neurology Library)
97% match

Multiple Sclerosis: Clinician's Guide To Diagnosis And Treatment (Oxford American Neurology Library)

Oxford University Press

£31.13 11 Jul 2026
Multiple Sclerosis: Causes, Diagnosis & Management (Immunology and Immune System Disorders)
97% match

Multiple Sclerosis: Causes, Diagnosis & Management (Immunology and Immune System Disorders)

£133.99 09 Jul 2026
Multiple Sclerosis: Methods and Protocols: 1304 (Methods in Molecular Biology, 1304)
97% match

Multiple Sclerosis: Methods and Protocols: 1304 (Methods in Molecular Biology, 1304)

Humana

£77.05 09 Jul 2026
Women and Multiple Sclerosis - Neurology Research Book
97% match

Women and Multiple Sclerosis - Neurology Research Book

£122.99 15 Jul 2026
Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies (Current Clinical Neurology)
97% match

Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies (Current Clinical Neurology)

Humana

£103.26 06 Jul 2026
Handbook of Multiple Sclerosis
97% match

Handbook of Multiple Sclerosis

Foster Academics

£73.36 04 Jul 2026
Multiple Sclerosis, An Issue of Neurologic Clinics (Volume 36-1) (The Clinics: Radiology, Volume 36-1)
97% match

Multiple Sclerosis, An Issue of Neurologic Clinics (Volume 36-1) (The Clinics: Radiology, Volume 36-1)

Elsevier

£62.87 15 Jul 2026
Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)
97% match

Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)

Wiley

£63.99 02 Jul 2026
Multiple Sclerosis Therapeutics
97% match

Multiple Sclerosis Therapeutics

Cambridge University Press

£41.49 29 Jun 2026
Multiple Sclerosis, An Issue of Neurologic Clinics: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)
97% match

Multiple Sclerosis, An Issue of Neurologic Clinics: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)

Elsevier

£65.98 02 Jul 2026
Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications
97% match

Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications

Academic Press

£79.88 15 Jul 2026
Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)
97% match

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)

Humana

£89.37 08 Jul 2026
Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases
96% match

Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases

Springer

£81.84 03 Jul 2026
The Clinical Neuropsychiatry of Multiple Sclerosis
96% match

The Clinical Neuropsychiatry of Multiple Sclerosis

Cambridge University Press

£59.19 16 Jul 2026
Mechanisms of Disease Pathogenesis in Multiple Sclerosis
96% match

Mechanisms of Disease Pathogenesis in Multiple Sclerosis

Academic Press

£98.96 09 Jul 2026
The Biology of Oligodendrocytes
96% match

The Biology of Oligodendrocytes

Cambridge University Press

£37.80 07 Jul 2026